BIIB CIK: 875045

Biogen Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
7.86
FY22:
9.79
FY23:
6.86
FY24:
7.46
FY25:
8.97
(positive)
Change from FY21 to FY25
billions USD
FY21:
16.0
FY22:
14.8
FY23:
20.0
FY24:
20.6
FY25:
20.5
Total assets
Change from FY21 to FY25
billions USD
FY21:
23.9
FY22:
24.6
FY23:
26.8
FY24:
28.0
FY25:
29.4

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
4.30
FY22:
3.27
FY23:
3.43
FY24:
5.53
FY25:
3.35
(negative)
Change from FY21 to FY25
billions USD
FY21:
8.62
FY22:
7.89
FY23:
8.61
FY24:
5.80
FY25:
7.83
(positive)
Change from FY21 to FY25
billions USD
FY21:
10.9
FY22:
13.4
FY23:
14.8
FY24:
16.7
FY25:
18.3
Total liabilities & equity
Change from FY22 to FY25
billions USD
FY21:
–
FY22:
24.6
FY23:
26.8
FY24:
28.0
FY25:
29.4

All amounts in billions USD Data source:SEC EDGAR